Try GOLD - Free
Eris to acquire 2 Biocon Bio units for ₹366 crore
Mint Mumbai
|November 09, 2023
Nephrology, dermatology units have 20 brands with ₹90 cr FY23 revenue
Eris Lifesciences Ltd. said it has signed a definitive agreement to purchase the nephrology and dermatology segments of Biocon Biologics Ltd.'s branded formulations business in India for ₹366 crore.
The acquired units, encompassing more than 20 major brands, reported a turnover of ₹90 crore in fiscal year 2023, with a current revenue run-rate of ₹100 crore.
The deal, which includes the transfer of working capital, will see over 120 personnel, including senior leaders and field staff, transition to Eris Lifesciences. The transaction is likely to achieve financial closure by the end of 2023.
This story is from the November 09, 2023 edition of Mint Mumbai.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Mint Mumbai
Mint Mumbai
Cement firms turn defensive as war shock spikes costs
Cement makers are responding with fuel substitution, long-term sourcing contracts
3 mins
May 15, 2026
Mint Mumbai
Tata Motors PV revenue dips
The firm posted its first annual revenue decline in five years and a FY26 operating loss, hurt by JLR headwinds
3 mins
May 15, 2026
Mint Mumbai
ASK launches ₹2,500-cr 2nd pvt credit fund
ASK Alternates, part of the Blackstone-backed ASK Asset & Wealth Management Group, launched its second private credit fund with a target corpus of ₹2,500 crore, including a ₹1,500 crore green-shoe option, a top executive at the company said.
1 min
May 15, 2026
Mint Mumbai
Kaynes Technology misses Street estimates, FY26 guidance
Kaynes Technology India plunged more than 19% on Thursday as India’s third-largest electronics manufacturer drew investor ire over missing revenue and cash flow targets and failing to provide guidance for 2026-27.
1 mins
May 15, 2026
Mint Mumbai
AI reshapes pricing models at top IT firms
Infosys, Cognizant see a rise in fixed-price and outcome-based contracts
3 mins
May 15, 2026
Mint Mumbai
Warsh confirmed to lead Fed in narrowest vote ever
The US Senate narrowly confirmed Kevin Warsh as chair of the Federal Reserve (Fed), setting up the most controversial leadership transition at the US central bank in decades and a test of its political independence.
1 min
May 15, 2026
Mint Mumbai
Honda posts first annual loss in 70 yrs
Honda Motor posted its first annual loss in nearly 70 years as a listed company on Thursday, hit by more than $9 billion in costs to restructure its electric-vehicle (EV) business, and the firm scrapped its long-term EV sales target.
1 min
May 15, 2026
Mint Mumbai
Sebi plans overhaul of commodity options framework
Market regulator Securities and Exchange Board of India (Sebi) on Thursday proposed removing the “close-to-the-money” (CTM) category in commodity options contracts as part of a broader clean-up of India’s derivatives regulations aimed at simplifying trading and reducing compliance burdens for exchanges.
1 min
May 15, 2026
Mint Mumbai
Why fast-food players are prepping fresh India serving
Several global brands that once struggled to find a foothold in India are eyeing a comeback
3 mins
May 15, 2026
Mint Mumbai
Wholesale inflation surges to 42-month high in April
A jump in crude oil prices in the wake of the West Asia war lifted wholesale inflation to 8.3%
2 mins
May 15, 2026
Translate
Change font size